尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Camerlinck Robert. Director active across 1 company, notably Cano Health, Inc.. Cumulatively, 7 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €21k. History available since 11 August 2023. The latest transaction was filed on 11 August 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Robert Camerlinck is a declarant linked to Cano Health, Inc. (XNAS), where he is Chief Operating Officer. The record shows 7 filings in total, and across the 7 sampled filings there were no buys and EUR 21357 of sells, with publications ranging from 2022-08-12 to 2024-07-02.